UNLABELLED The survival rate of cancer patients has greatly increased over the last 20 years. However, to achieve this result, a considerable price has been paid in terms of the side effects associated with the intensive anticancer treatment. The most common adverse effect is cardiotoxicity which may compromise the clinical effectiveness of chemotherapy, affecting the patient's survival and qua...

introduction: differentiating between ischemic cardiomyopathy (icm) and idiopathic dilated cardiomyopathy (idcm) is important as coronary revascularization can improve prognosis in the ischemic subgroup. due to inherent problems of coronary angiography in patients with depressed ejection fraction (ef) introducing a noninvasive tool to diagnose those who will benefit from angiography seems to be...

Cardiovascular complications have been well documented as the downside to conventional cancer chemotherapy. As a notable side effect of cisplatin (CDDP), cardiotoxicity represents major obstacle successful treatment cancer. It has reported that Salvianolic acid B (SalB) possesses cardioprotective quality. However, SalB on cardiac damage caused by chemotherapy remains unclear. In this study, we ...

Chemotherapy-induced cardiomyopathy (CCMP) is a significant cause of morbidity and mortality. Compared to cardiomyopathy due to other causes, anthracycline-induced cardiomyopathy is associated with a worse survival. As cancer survival improves, patients with CCMP can be expected to comprise a significant proportion of patients who may require advanced therapies such as inotropic support, cardia...